Related Experiment Video
Updated: Jun 20, 2026
08:49
Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
Serotonin receptors, type 4: a new hope?
1Centre de Recherche Fernand Séguin (Université de Montréal), 7331 rue Hochelaga, Montréal, Québec, H1N 3V2 Canada. guillaume.lucas@gmail.com
Current Drug Targets
|August 26, 2009
Summary
Serotonin(4) (5-HT(4)) receptor agonists show potential as fast-acting antidepressants by modulating central serotonin neurotransmission. Further research into these receptors may offer new therapeutic avenues for depression treatment.
Area of Science:
- Neuroscience
- Pharmacology
- Gastroenterology
Background:
- Serotonin(4) (5-HT(4)) receptors regulate diverse physiological functions, including gastrointestinal motility, memory, and neurotransmitter release.
- These receptors are implicated in central nervous system functions, influencing mood and cognition.
Purpose of the Study:
- To explore the potential of serotonin(4) receptor agonists as novel antidepressants.
- To investigate the role of 5-HT(4) receptors in modulating central serotonin neurotransmission.
Main Methods:
- Review of existing studies on 5-HT(4) receptor function.
- Analysis of the impact of 5-HT(4) receptor modulation on central 5-HT neurotransmission.
Main Results:
- Evidence suggests 5-HT(4) receptors play a key role in regulating both pre- and postsynaptic central serotonin activity.
- Agonists targeting 5-HT(4) receptors may offer a fast-acting antidepressant effect.
Conclusions:
- The study of serotonin(4) receptors presents a promising new direction for depression therapeutics.
- Understanding the physiological role of 5-HT(4) receptor-mediated neurotransmission control opens new research avenues.
Related Concept Videos
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:31Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...